Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Obese Non-Diabetic HFpEF
NCT05847244Phase 2Unknown
- Start
- Oct 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in heart failure with preserved ejection fraction (HFpEF). Status: unknown.
02
Drugs
metformin
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT05847244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05847244.